Artificial intelligence can cut the diagnosis of blood clots in the lungs to a few minutes, instead of hours. And an ...

"I died on a plane three months ago," 34-year-old Emily Jansson said, as she went into cardiac arrest on the long-haul flight.

Two med-tech companies focused on pulmonary embolism overcame their own blockages to commercialization this week. Inquis Medical Inc.’s Aventus thrombectomy system received U.S. FDA clearance for use ...

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced the completion of enrollment in the STORM-PE ...

Pulmonary embolism (PE) remains one of the leading causes of maternal mortality. At the French Thoracic Society Spring Days ...